These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16416872)

  • 1. [Gene therapy for lysosomal disorders].
    Ohashi T
    Nihon Rinsho; 2005 Dec; 63 Suppl 12():671-8. PubMed ID: 16416872
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lysosomes and lysosomal storage diseases].
    Germain DP
    J Soc Biol; 2002; 196(2):127-34. PubMed ID: 12360741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mini review: animal model of human lysosomal storage disease].
    Sakiyama T
    Nihon Rinsho; 1995 Dec; 53(12):3105-11. PubMed ID: 8577067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for the lysosomal storage disorders.
    Cabrera-Salazar MA; Novelli E; Barranger JA
    Curr Opin Mol Ther; 2002 Aug; 4(4):349-58. PubMed ID: 12222873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on gene therapy for lysosomal storage diseases that affect hematopoiesis.
    Grabowski GA
    Curr Hematol Rep; 2003 Jul; 2(4):356-62. PubMed ID: 12901334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of nonviral promoters in adenovirus-mediated gene therapy: reduction of lysosomal storage in the aspartylglucosaminuria mouse.
    Virta S; Rapola J; Jalanko A; Laine M
    J Gene Med; 2006 Jun; 8(6):699-706. PubMed ID: 16518877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy progress and prospects: gene therapy of lysosomal storage disorders.
    Cheng SH; Smith AE
    Gene Ther; 2003 Aug; 10(16):1275-81. PubMed ID: 12883523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation and gene therapy for lysosomal storage diseases.
    Hoogerbrugge PM; Valerio D
    Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S34-6. PubMed ID: 9630322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow transplantation therapy for metabolic disease: animal models as predictors of success and in utero approaches.
    Haskins M
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S25-7. PubMed ID: 8971403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Particularities of lysosomal storage diseases gene therapy.
    Poenaru L
    Gene Ther; 1996 Dec; 3(12):1039-41. PubMed ID: 8986430
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene therapy for lysosomal storage disorders.
    Yew NS; Cheng SH
    Curr Opin Mol Ther; 2001 Aug; 3(4):399-406. PubMed ID: 11525564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysosomal storage disorders: the need for better pediatric recognition and comprehensive care.
    Wilcox WR
    J Pediatr; 2004 May; 144(5 Suppl):S3-14. PubMed ID: 15126978
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene therapy for lysosomal storage diseases.
    Sands MS; Davidson BL
    Mol Ther; 2006 May; 13(5):839-49. PubMed ID: 16545619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment prospects of lysosomal storage disorders].
    Reismann P; Tulassay Z
    Orv Hetil; 2008 Jun; 149(25):1171-9. PubMed ID: 18547894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for lysosomal disorders.
    Naffakh N; Bohl D; Salvetti A; Moullier P; Danos O; Heard JM
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S11-6. PubMed ID: 8177709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatments for lysosomal storage disorders.
    Lachmann R
    Biochem Soc Trans; 2010 Dec; 38(6):1465-8. PubMed ID: 21118108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated gene transfer results in decreased lysosomal storage in brain and total correction in liver of aspartylglucosaminuria (AGU) mouse.
    Peltola M; Kyttälä A; Heinonen O; Rapola J; Paunio T; Revah F; Peltonen L; Jalanko A
    Gene Ther; 1998 Oct; 5(10):1314-21. PubMed ID: 9930336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and application of replication-incompetent HSV-1-based vectors.
    Berto E; Bozac A; Marconi P
    Gene Ther; 2005 Oct; 12 Suppl 1():S98-102. PubMed ID: 16231061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gene therapy for lysosomal storage diseases].
    Ohashi T
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():665-9. PubMed ID: 20979313
    [No Abstract]   [Full Text] [Related]  

  • 20. Engraftment of genetically engineered amniotic epithelial cells corrects lysosomal storage in multiple areas of the brain in mucopolysaccharidosis type VII mice.
    Kosuga M; Sasaki K; Tanabe A; Li XK; Okawa H; Ogino I; Okuda O; Arai H; Sakuragawa N; Kamata Y; Azuma N; Suzuki S; Yamada M; Okuyama T
    Mol Ther; 2001 Feb; 3(2):139-48. PubMed ID: 11237670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.